Magdalena_Krzystolik@meei.harvard.edu
For investigator inquiries only
About My Research
Center/Research Area Affiliations
Biography
Dr. Krzystolik's research focuses on antiangiogenic treatments for retinal diseases and integrating retinal surgery into the ophthalmic graduate medical education curriculum.
Education
1993: MD, Pritzker School of Medicine, University of Chicago
Postgraduate Training
1993-1994: Internal Medicine Resident, University of Chicago
1994-1997: Ophthalmology Resident, Harvard Medical School
1996: Visiting Resident Surgeon, Aravind Eye Hospital
2013-2014: Vitreoretinal Fellow, Mass. Eye and Ear
Academic Appointments
1997-2000: Clinical Instructor in Ophthalmology, Massachusetts Eye and Ear
2001-2013: Clinical Assistant Professor of Ophthalmology, Alpert Medical School of Brown University
2011: Visiting Lecturer, Melenik II Eye Hospital, Retina Clinica, Addis Ababa, Ethiopia
2013-2014: Clinical Associate pRofessor of Ophthalmology, Alpert Medical School of Brown University
2014-present: Adjunct Clinical Associate Professor of Ophthalmology, Alpert Medical School of Brown University
2014-2016: Member of the Faculty of Ophthalmology, Harvard Medical School
2016-present: Assistant Professor of Ophthalmology, Harvard Medical School
Professional Memberships
1998-present: American Academy of Ophthalmology, Member
2002-present: Rhode Island Society of Eye Physicians and Surgeons, Treasurer (2011-2013); Vice President (2013-2016); President (2016-2018)
2003-present: New England Ophthalmological Society, Nominating Committee (2006-2012); Public Health and Education Committee (2007-2017); Program Committee (2018-present)
2003-present: American Society of Retina Specialists, Member
2005-present: Rhode Island Medical Women's Association, Member
2006-present: Rhode Island Medical Society, Member
2006-present: Massachusetts Society of Eye Physicians and Surgeons, Member
Honors
1993: American Women Medical Association for Scholastic Achievement
1998-1999: Heed Foundation Fellowship
2000: Travel Award of the Retina Society
2013: Teaching Excellence Award, Alpert Medical School of Brown University/Department of Ophthalmology
- Ocular Blast Injuries in Military and Civilian Mass-casualty Settings. Int Ophthalmol Clin. 2024 Apr 01; 64(2):209-220.
- A 5-Year Retrospective Assessment of Clinical Presentation Associated With Sports Injury in Young People Presenting to a Tertiary Eye Center. J Pediatr Ophthalmol Strabismus. 2021 Nov-Dec; 58(6):377-384.
- The Use of Mobile Applications as Low-Vision Aids: A Pilot Study. R I Med J (2013). 2020 Oct 01; 103(8):69-72.
- The Ocular Manifestations and Transmission of COVID-19: Recommendations for Prevention. J Emerg Med. 2020 07; 59(1):137-140.
- Treatment regimens for administration of anti-vascular endothelial growth factor agents for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2020 05 05; 5:CD012208.
- Anti-vascular endothelial growth factor for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2019 03 04; 3:CD005139.
- Cost and Selection of Ophthalmic Anti-Vascular Endothelial Growth Factor Agents. R I Med J (2013). 2016 May 02; 99(5):15-7.
- Intravitreal Bevacizumab Versus Ranibizumab for Treatment of Neovascular Age-Related Macular Degeneration: Findings from a Cochrane Systematic Review. Ophthalmology. 2016 Jan; 123(1):70-77.e1.
- Wyburn-Mason Syndrome Associated With Cutaneous Reactive Angiomatosis and Central Retinal Vein Occlusion. Ophthalmic Surg Lasers Imaging Retina. 2015 Jul-Aug; 46(7):760-2.
- Nurse-administered intravitreal injections: a systematic review. Graefes Arch Clin Exp Ophthalmol. 2015 Sep; 253(9):1619-21.
- Anti-vascular endothelial growth factor for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2014 Aug 29; (8):CD005139.
- Guideline-adherent aspirin use in individuals with age-related macular degeneration. J Am Geriatr Soc. 2013 Jun; 61(6):1033-1034.
- Avastin doesn't blind people, people blind people. Am J Ophthalmol. 2012 Sep; 154(3):610; author reply 610-1.
- Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2008 Apr 16; (2):CD005139.
- Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema. Ophthalmology. 2007 Aug; 114(8):1520-5.
- Predictors of visual outcome and choroidal neovascular membrane formation after traumatic choroidal rupture. Arch Ophthalmol. 2006 Jul; 124(7):957-66.
- Pegaptanib as an adjunctive treatment for complicated neovascular diabetic retinopathy. Arch Ophthalmol. 2006 Jun; 124(6):920-1.
- Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol. 2002 Mar; 120(3):338-46.
- The murine cone photoreceptor: a single cone type expresses both S and M opsins with retinal spatial patterning. Neuron. 2000 Sep; 27(3):513-23.
- Complications of intraocular tamponade: silicone oil versus intraocular gas. Int Ophthalmol Clin. 2000; 40(1):187-200.
- Evolution of a full-thickness macular hole. Am J Ophthalmol. 1998 Feb; 125(2):245-7.
- Diagnostic and therapeutic challenges of sarcoidosis. Int Ophthalmol Clin. 1998; 38(1):61-76.
- Exogenous Aspergillus niger endophthalmitis in a patient with a filtering bleb. Retina. 1997; 17(5):461-2.
- Anterior-segment ultrasound biomicroscopy in a patient with AIDS and bilateral angle-closure glaucoma secondary to uveal effusions. Arch Ophthalmol. 1996 Jul; 114(7):878-9.
- Orbit and adnexal neoplasia. Curr Opin Ophthalmol. 1995 Oct; 6(5):78-85.
- Developmental expression of S103L cross-reacting proteoglycans in embryonic chick. Prog Clin Biol Res. 1993; 383B:505-14.
Show More
Show Less
